Undifferentiated lower gastrointestinal bleeding

(Redirected from Lower GI bleeding)
This page contains changes which are not marked for translation.


Background

Gasterointestinal anatomy.
Layers of the Alimentary Canal. The wall of the alimentary canal has four basic tissue layers: the mucosa, submucosa, muscularis, and serosa.
  • Loss of blood from the GI tract distal to the ligament of Treitz
  • Must consider upper GI bleed (especially rapid transit) as a source, as a significant number of lower GI bleeds have a concurrent upper GI bleed, brisk or not[2]
  • 80% of lower GI bleeding will resolve spontaneously[3]


Medication Risk Factors


Clinical Features

Type of blood

  • Hematochezia
    • Usually represents lower GI bleeding
    • Left colonic bleeding tends to be bright red, whereas right colonic is usually maroon and mixed with stool[4]
    • May represent upper GI source if bleeding is brisk; usually accompanied by hematemesis and hemodynamic instability
  • Melena
    • Usually represents bleeding from upper GI source (see upper GI bleed)
    • May represent slow bleeding or slow stool transit from lower GI source


Differential Diagnosis

Undifferentiated lower gastrointestinal bleeding


Evaluation

Fecal Occult Blood Test showing positive (A) and positive control (B).
  • Digital rectal exam for guaiac or assessment of anorectal structural abnormalities
    • Note that guaiac tests have low sensitivity, many false positive etiologies (red meat, red jello, certain fruits/veggies, iron), and may not change management clinically
  • Consider chart review to search for prior colonoscopy/endoscopy results


Workup

  • CBC
    • Consider q3-12hr serial Hgb, depending on suspected severity of bleed
    • Initial Hgb may be normal if bleeding is acute
  • CMP
    • BUN may be elevated if bleeding occurs from site high in GI tract, due to heme digestion to nitrogenous substances reflected in BUN[5]
  • Coags
  • Type and screen/cross
  • Consider:
    • CTA; Requires brisk bleeding rate (0.4-0.5 ml/min) for detection[6]
    • Tagged red blood cell scan. This is not typically an emergency study and is only recommended if CTA is unavailable or contraindicated
    • ECG (if concern for silent ischemia in patients likely to have CAD)
    • Fibrinogen


Definitive studies

  • Consider:
    • Anoscopy if source of bleeding cannot be identified on external exam
    • Proctoscopy (22cm from anal verge)
    • Sigmoidoscopy (60cm from anal verge)


Management

  • NPO, if there is foreseeable endoscopy or surgery
  • Fluid resuscitation for all
  • Consider transfusing pRBCs/platelets for unstable patients or with very low hemoglobin (<7). with cardiovascular disease use trigger of 8 and target of 10 hemoglobin.
    • Base decision to transfuse on individual clinical factors. Active bleeding and tachycardia may call for transfusion despite a normal Hgb

Categorize as stable versus unstable using shock index: <1 stable; >1 unstable or suspect active bleeding

  • Unstable
    • CT angiography is preferred for hemodynamically unstable patients due to speed[7]
      • Positive CTA demonstrating extravasation/blush calls for IR consult for transcatheter arteriography and subsequent embolization.
    • Consult GI for emergent colonoscopy, as it is the diagnostic/therapeutic procedure of choice (within 12-24 hours); upper endoscopy may be needed if CTA does not reveal source of GI bleeding
      • Patients with a positive CTA are more likely to have a source found on subsequent colonoscopy
    • Consult surgery if endoscopy and IR embolization fail or are not available
  • Stable
    • See "Disposition"


Major Bleed and Existing Coagulopathy

  • Correct coagulopathy
  • PCC (preferred) or FFP for patients on warfarin
    • Vitamin K 10mg IV (best bioavailability in critical patients)
  • Consider targeted reversal agents for DOACs in life-threatening LGIB refractory to initial resuscitation treatments, if the DOAC was taken in the past 24 hours: See Anticoagulant reversal for life-threatening bleeds
  • Platelets should be administered to thrombocytopenic patients to a goal of 30-50, depending if endoscopy is planned[8]
  • ACG recommends against Tranexamic acid as it has no evidence for benefit but may increase VTE


Special situations

  • Marathon runners - 16% will have hematochezia within 24-48 hrs of race and 85% will be guaiac positive[9]
    • Non-actionable unless abdominal pain present


Disposition

Discharge

  • Oakland score can help determine if outpatient management is feasible; a score of <8 can be considered for safe discharge[10]
    • Based on a recent meta-analysis, the Oakland score, compared to other LGIB risk scores, has good performance in predicting safe discharge, major bleeding, and need for transfusion[11]
  • Bleeding from hemorrhoids, anal fissures, or known IBD (hemodynamically stable)
  • Minor, self-terminating bleed with no other indication for admission (shock index >1; low risk score calculated)


Admission

  • Melena
  • Significant anemia
  • Hemodynamic instability
  • Identified as high risk based on Oakland score


See Also

Gastrointestinal Bleeding Pages


References

  1. Farrell JJ, Friedman LS. Review article: the management of lower gastrointestinal bleeding. Aliment Pharmacol Ther. 2005 Jun 1;21(11):1281-98. doi: 10.1111/j.1365-2036.2005.02485.x. PMID: 15932359.
  2. Amin SK, Antunes C. Lower Gastrointestinal Bleeding. [Updated 2023 Jul 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK448126
  3. Farrell JJ, Friedman LS. Review article: the management of lower gastrointestinal bleeding. Aliment Pharmacol Ther. 2005 Jun 1;21(11):1281-98. doi: 10.1111/j.1365-2036.2005.02485.x. PMID: 15932359.
  4. Frost J, Sheldon F, Kurup A, Disney BR, Latif S, Ishaq S. An approach to acute lower gastrointestinal bleeding. Frontline Gastroenterol. 2017 Jul;8(3):174-182. doi: 10.1136/flgastro-2015-100606. Epub 2015 Jun 29. PMID: 28839906; PMCID: PMC5558275.
  5. Patel, Sneha MD; Peraza, Jellyana MD; Hasani, Aliaskar MD; Luther, Sanjana MD; Chugh, Rishika MD; Tokayer, Aaron MD, FACG. 611 Finding the Ideal BUN to Creatinine Ratio in an Upper GI Bleed. The American Journal of Gastroenterology 114():p S355, October 2019. | DOI: 10.14309/01.ajg.0000591980.77707.20
  6. Serur A, Rhee R, Ramjist J. Current Nonoperative Therapeutic Interventions for Lower Gastrointestinal Hemorrhage. Clin Colon Rectal Surg. 2020 Jan;33(1):22-27. doi: 10.1055/s-0039-1695033. Epub 2019 Nov 11. PMID: 31915422; PMCID: PMC6946602.
  7. Oakland K, Chadwick G, East JE, et al. Diagnosis and management of acute lower gastrointestinal bleeding: guidelines from the British Society of Gastroenterology. Gut 2019;67:776-789.
  8. Sengupta, N., Feuerstein, J. D., Jairath, V., Shergill, A. K., Strate, L. L., Wong, R. J., & Wan, D. (2023). Management of Patients With Acute Lower Gastrointestinal Bleeding: An Updated ACG Guideline. The American journal of gastroenterology, 118(2), 208–231. https://doi.org/10.14309/ajg.0000000000002130
  9. Sullivan SN, Wong C. Runners' diarrhea. Different patterns and associated factors. J Clin Gastroenterol 1992;14:101-104.
  10. Oakland K, Jairath V, Uberoi R, Guy R, Ayaru L, Mortensen N, Murphy MF, Collins GS. Derivation and validation of a novel risk score for safe discharge after acute lower gastrointestinal bleeding: a modelling study. Lancet Gastroenterol Hepatol. 2017 Sep;2(9):635-643. doi: 10.1016/S2468-1253(17)30150-4. Epub 2017 Jun 23. PMID: 28651935.
  11. Almaghrabi M, Gandhi M, Guizzetti L, et al. Comparison of Risk Scores for Lower Gastrointestinal Bleeding: A Systematic Review and Meta-analysis. JAMA Netw Open. 2022;5(5):e2214253. doi:10.1001/jamanetworkopen.2022.14253